Rx-Info Limited 04981011 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is software development and publishing. Digita Accounts Production Advanced 6.30.9574.0 true true true 04981011 2024-01-01 2024-12-31 04981011 2024-12-31 04981011 core:RetainedEarningsAccumulatedLosses 2024-12-31 04981011 core:ShareCapital 2024-12-31 04981011 core:SharePremium 2024-12-31 04981011 core:CurrentFinancialInstruments 2024-12-31 04981011 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 04981011 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 04981011 core:FurnitureFittingsToolsEquipment 2024-12-31 04981011 core:MotorVehicles 2024-12-31 04981011 1 2024-12-31 04981011 bus:SmallEntities 2024-01-01 2024-12-31 04981011 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 04981011 bus:FilletedAccounts 2024-01-01 2024-12-31 04981011 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04981011 bus:RegisteredOffice 2024-01-01 2024-12-31 04981011 bus:CompanySecretary1 2024-01-01 2024-12-31 04981011 bus:Director1 2024-01-01 2024-12-31 04981011 bus:Director2 2024-01-01 2024-12-31 04981011 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04981011 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 04981011 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 04981011 core:MotorVehicles 2024-01-01 2024-12-31 04981011 1 2024-01-01 2024-12-31 04981011 countries:EnglandWales 2024-01-01 2024-12-31 04981011 1 2024-01-01 2024-12-31 04981011 2023-12-31 04981011 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 04981011 core:FurnitureFittingsToolsEquipment 2023-12-31 04981011 core:MotorVehicles 2023-12-31 04981011 1 2023-12-31 04981011 2023-01-01 2023-12-31 04981011 2023-12-31 04981011 core:RetainedEarningsAccumulatedLosses 2023-12-31 04981011 core:ShareCapital 2023-12-31 04981011 core:SharePremium 2023-12-31 04981011 core:CurrentFinancialInstruments 2023-12-31 04981011 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 04981011 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 04981011 core:FurnitureFittingsToolsEquipment 2023-12-31 04981011 core:MotorVehicles 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 04981011

Rx-Info Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Rx-Info Limited
(Registration number: 04981011)

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

Rx-Info Limited
(Registration number: 04981011)

Company Information

Directors

Mr C E Richman

Mr J Kerr

Company secretary

Mrs C Richman

Registered office

1 Colleton Crescent
Exeter
Devon
EX2 4DG

Accountants

Thompson Jenner LLP
Chartered Accountants
1 Colleton Crescent
Exeter
Devon
EX2 4DG

 

Rx-Info Limited
(Registration number: 04981011)

Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

647,761

630,178

Tangible assets

5

145,938

190,370

 

793,699

820,548

Current assets

 

Debtors

6

961,325

1,629,652

Cash at bank and in hand

 

380,072

214,663

 

1,341,397

1,844,315

Creditors: Amounts falling due within one year

7

(810,573)

(1,785,940)

Net current assets

 

530,824

58,375

Total assets less current liabilities

 

1,324,523

878,923

Provisions for liabilities

(182,745)

(190,787)

Net assets

 

1,141,778

688,136

Capital and reserves

 

Called up share capital

2,000

2,000

Share premium reserve

900

900

Retained earnings

1,138,878

685,236

Shareholders' funds

 

1,141,778

688,136

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Rx-Info Limited
(Registration number: 04981011)

Balance Sheet as at 31 December 2024

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 10 April 2025 and signed on its behalf by:
 

.........................................
Mr C E Richman
Director

.........................................
Mr J Kerr
Director

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1 Colleton Crescent
Exeter
Devon
EX2 4DG

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and the contracted service has been provided.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings and equipment

25% reducing balance

Motor vehicles

25% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Development costs

25% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 10 (2023 - 10).

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Intangible assets

Development costs
 £

Total
£

Cost or valuation

At 1 January 2024

3,046,412

3,046,412

Additions acquired separately

323,738

323,738

At 31 December 2024

3,370,150

3,370,150

Amortisation

At 1 January 2024

2,416,234

2,416,234

Amortisation charge

306,155

306,155

At 31 December 2024

2,722,389

2,722,389

Carrying amount

At 31 December 2024

647,761

647,761

At 31 December 2023

630,178

630,178

5

Tangible assets

Fixtures, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 January 2024

109,878

185,219

295,097

Additions

8,793

-

8,793

At 31 December 2024

118,671

185,219

303,890

Depreciation

At 1 January 2024

83,732

20,995

104,727

Charge for the year

6,920

46,305

53,225

At 31 December 2024

90,652

67,300

157,952

Carrying amount

At 31 December 2024

28,019

117,919

145,938

At 31 December 2023

26,146

164,224

190,370

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Debtors

2024
 £

2023
 £

Trade debtors

86,468

300,258

Amounts owed by group undertakings and undertakings in which the company has a participating interest

692,976

1,288,125

Other debtors

160,260

8,618

Prepayments and accrued income

21,621

32,651

Total current trade and other debtors

961,325

1,629,652

7

Creditors

Note

2024
 £

2023
 £

Due within one year

 

Trade creditors

 

5,438

3,435

Amounts owed to group undertakings and undertakings in which the company has a participating interest

9

-

1,103

Taxation and social security

 

56,996

64,898

Deferred income

 

705,668

1,696,174

Accrued expenses

 

24,704

20,070

Corporation tax liability

 

371

-

Other creditors

 

17,396

260

 

810,573

1,785,940

8

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £18,137 (2023 - £18,137).

 

Rx-Info Limited
(Registration number: 04981011)

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

9

Related party transactions

Transactions with directors

2024

At 1 January 2024
£

Advances to director
£

At 31 December 2024
£

Director 1 loan account (interest free and repayable on demand)

-

(160,260)

(160,260)

-

(160,260)

(160,260)

 

10

Parent and ultimate parent undertaking

The company's immediate parent is RX-Info Holdings Limited, incorporated in England & Wales.

 The ultimate controlling party is C Richman.